The stock price of Transmedics Group Inc (NASDAQ: TMDX) has dropped by -13.53 compared to previous close of 85.14. Despite this, the company has seen a fall of -6.31% in its stock price over the last five trading days. benzinga.com reported 2024-12-03 that U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday.
Is It Worth Investing in Transmedics Group Inc (NASDAQ: TMDX) Right Now?
Transmedics Group Inc (NASDAQ: TMDX) has a price-to-earnings ratio of 78.87x that is above its average ratio. Additionally, the 36-month beta value for TMDX is 2.06. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 3 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for TMDX is 32.44M and currently, short sellers hold a 27.67% ratio of that float. The average trading volume of TMDX on December 03, 2024 was 1.64M shares.
TMDX’s Market Performance
TMDX’s stock has seen a -6.31% decrease for the week, with a -10.66% drop in the past month and a -51.24% fall in the past quarter. The volatility ratio for the week is 4.50%, and the volatility levels for the past 30 days are at 5.62% for Transmedics Group Inc. The simple moving average for the past 20 days is -11.89% for TMDX’s stock, with a -39.64% simple moving average for the past 200 days.
Analysts’ Opinion of TMDX
Oppenheimer, on the other hand, stated in their research note that they expect to see TMDX reach a price target of $125, previously predicting the price at $200. The rating they have provided for TMDX stocks is “Outperform” according to the report published on October 29th, 2024.
Needham gave a rating of “Buy” to TMDX, setting the target price at $109 in the report published on October 29th of the current year.
TMDX Trading at -33.03% from the 50-Day Moving Average
After a stumble in the market that brought TMDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.49% of loss for the given period.
Volatility was left at 5.62%, however, over the last 30 days, the volatility rate increased by 4.50%, as shares sank -12.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -53.40% lower at present.
During the last 5 trading sessions, TMDX fell by -5.41%, which changed the moving average for the period of 200-days by -17.35% in comparison to the 20-day moving average, which settled at $83.59. In addition, Transmedics Group Inc saw -6.73% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TMDX starting from Khayal Tamer I, who sale 1,458 shares at the price of $90.04 back on Nov 11 ’24. After this action, Khayal Tamer I now owns 20,843 shares of Transmedics Group Inc, valued at $131,278 using the latest closing price.
Basile Edward M, the Director of Transmedics Group Inc, sale 6,750 shares at $83.55 during a trade that took place back on Nov 05 ’24, which means that Basile Edward M is holding 732 shares at $563,994 based on the most recent closing price.
Stock Fundamentals for TMDX
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.59 for the gross margin
The net margin for Transmedics Group Inc stands at 0.08. The total capital return value is set at 0.04. Equity return is now at value 19.41, with 4.43 for asset returns.
Based on Transmedics Group Inc (TMDX), the company’s capital structure generated 0.71 points at debt to capital in total, while cash flow to debt ratio is standing at 0.07. The debt to equity ratio resting at 2.43. The interest coverage ratio of the stock is 2.91.
Currently, EBITDA for the company is -7.6 million with net debt to EBITDA at 3.23. When we switch over and look at the enterprise to sales, we see a ratio of 6.58. The receivables turnover for the company is 4.45for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.20.
Conclusion
In conclusion, Transmedics Group Inc (TMDX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
